Lalitha Renjini, Hicks Matthew, Qureshi Mosarrat, Kumaran Kumar
Department of Pediatrics, Division of Neonatal-Perinatal Medicine University of Western Ontario London Ontario Canada.
Department of Pediatrics Division of Neonatal-Perinatal Medicine Edmonton Alberta Canada.
JPGN Rep. 2024 May 20;5(3):256-264. doi: 10.1002/jpr3.12081. eCollection 2024 Aug.
To explore risk factors for Stage-III necrotizing enterocolitis (NEC-III) in preterm neonates.
This was a retrospective case-control study of neonates born <33 weeks gestational age (GA) who were admitted to a tertiary neonatal intensive care unit, between 2015 and 2018. NEC-III cases were compared with Stage-II NEC (NEC-II) and non-NEC controls. Two to four non-NEC controls were matched by GA ± 1 week and date of birth ± 3 months, to one NEC-III case. Univariate and multivariate analyses were used to examine risk factors for NEC-III.
Of 1360 neonates born <33 weeks, 71 (5.2%) had NEC-II and above, with 46% being NEC-III. Mean age of onset of NEC-III was 13.7 days versus 23.9 days for NEC-II ( = 0.01). Neonates with NEC-III were of lower GA (NEC-III 25.4 weeks, NEC-II 27.3 weeks, and non-NEC 26 weeks; = 0.0008) and had higher Score for Neonatal Acute Physiology Perinatal Extension-II scores (NEC-III 47.5, NEC-II 28.4 and non-NEC 37, = 0.003). Multivariate analysis showed duration of umbilical arterial catheter (UAC) >5 days was significantly associated with the development of NEC-III with adjusted odds ratio (AOR) 3.8; 95% confidence interval (CI) (1.05-13.66) for NEC-III versus non-NEC and AOR 5.57; 95% CI (1.65-18.73), = 0.006 for NEC-III versus NEC-II. Rupture of membranes (ROM) >1 week was associated with NEC-III (AOR 6.93; 95% CI [1.56-30.69] vs. non-NEC and AOR 11.74; 95% CI [1.14-120.34] vs. NEC-II).
The increased association of NEC-III with duration of UAC and ROM could be further examined in prospective studies, and an upper limit for UAC duration could be considered in NEC prevention bundles.
探讨早产儿Ⅲ期坏死性小肠结肠炎(NEC-Ⅲ)的危险因素。
这是一项回顾性病例对照研究,研究对象为2015年至2018年间入住三级新生儿重症监护病房、胎龄小于33周(GA)的新生儿。将NEC-Ⅲ病例与Ⅱ期NEC(NEC-Ⅱ)及非NEC对照组进行比较。按照胎龄±1周和出生日期±3个月,将2至4名非NEC对照与1例NEC-Ⅲ病例进行匹配。采用单因素和多因素分析来研究NEC-Ⅲ的危险因素。
在1360例胎龄小于33周的新生儿中,71例(5.2%)患有NEC-Ⅱ及以上疾病,其中46%为NEC-Ⅲ。NEC-Ⅲ的平均发病年龄为13.7天,而NEC-Ⅱ为23.9天(P=0.01)。NEC-Ⅲ新生儿的胎龄更低(NEC-Ⅲ为25.4周,NEC-Ⅱ为27.3周,非NEC为26周;P=0.0008),且新生儿急性生理学围产期扩展Ⅱ评分更高(NEC-Ⅲ为47.5,NEC-Ⅱ为28.4,非NEC为37;P=0.003)。多因素分析显示,脐动脉导管(UAC)留置时间>5天与NEC-Ⅲ的发生显著相关,与非NEC相比,NEC-Ⅲ的调整优势比(AOR)为3.8;95%置信区间(CI)为(1.05-13.66),与NEC-Ⅱ相比,AOR为5.57;95%CI为(1.65-18.73),P=0.006。胎膜破裂(ROM)>1周与NEC-Ⅲ相关(与非NEC相比,AOR为6.93;95%CI[1.56-30.69],与NEC-Ⅱ相比,AOR为11.74;95%CI[1.14-120.34])。
NEC-Ⅲ与UAC留置时间和ROM之间增加的相关性可在前瞻性研究中进一步检验,并且在NEC预防方案中可考虑设定UAC留置时间的上限。